A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis. 1983

T Fredriksson

A trial was carried out in 60 patients with relatively stable psoriasis to compare the effectiveness, tolerance and cosmetic properties of dithranol in a cream base (0.1% and 0.25%) or in the form of a soft paraffin ointment (0.25%). Patients were assigned at random to receive treatment with one or other of the three formulations, applied once daily, over a period of 4 weeks. Assessments were made initially and after 2 and 4 weeks of induration, redness, scaling and pruritus and during the trial of staining of clothes and linen, skin discolouration and burning. There was no significant difference in effect between dithranol cream 0.25% and dithranol ointment 0.25%, while both showed a better effect than dithranol cream 0.1% (p less than 0.05). The dithranol cream preparations were significantly better (p less than 0.05) than dithranol ointment 0.25% regarding all the cosmetic variables after 2 as well as after 4-weeks' treatment. The same applied to the patients' overall evaluation of the cosmetic acceptability. Three patients in the dithranol ointment group were considered as treatment failures. One of them refused to continue with the treatment due to burning and another due to burning and staining.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Fredriksson
December 1982, The Australasian journal of dermatology,
T Fredriksson
February 1984, The Practitioner,
Copied contents to your clipboard!